IL1B and type 2 diabetes mellitus: In addition, IL-1β, IFN-γ, and D-dimer emerged as independent predictors of gastrointestinal complications, reinforcing the critical role of systemic inflammation in developing these adverse effects, particularly in patients with HIV and type II diabetes.